tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:2616 Stock Latest News

CStone Wins Second UK Approval for Lung Cancer Drug Sugemalimab
Company AnnouncementsCStone Wins Second UK Approval for Lung Cancer Drug Sugemalimab
3d ago
2616
CStone Wins U.S. FDA Green Light for Phase II Trial of Trispecific Cancer Antibody CS2009
PremiumCompany Announcements
CStone Wins U.S. FDA Green Light for Phase II Trial of Trispecific Cancer Antibody CS2009
10d ago
2616
CStone Pharmaceuticals Streamlines Company Secretary and Authorized Representative Roles
PremiumCompany Announcements
CStone Pharmaceuticals Streamlines Company Secretary and Authorized Representative Roles
19d ago
2616
CStone Pharmaceuticals Sets March Board Meeting and Investor Call to Detail 2025 Results and Oncology Pipeline Progress
PremiumCompany Announcements
CStone Pharmaceuticals Sets March Board Meeting and Investor Call to Detail 2025 Results and Oncology Pipeline Progress
23d ago
2616
CStone CEO Boosts Stake to 4.87% in Sign of Long-Term Confidence
PremiumCompany Announcements
CStone CEO Boosts Stake to 4.87% in Sign of Long-Term Confidence
30d ago
2616
CStone Pharmaceuticals Grants New Share Options and RSUs, Seeks Shareholder Nod for Director Awards
PremiumCompany AnnouncementsCStone Pharmaceuticals Grants New Share Options and RSUs, Seeks Shareholder Nod for Director Awards
1M ago
2616
CStone Pharmaceuticals Reshapes Board With New Independent Director Appointment
Premium
Company Announcements
CStone Pharmaceuticals Reshapes Board With New Independent Director Appointment
1M ago
2616
CStone Pharmaceuticals Sets Out Board and Committee Structure
Premium
Company Announcements
CStone Pharmaceuticals Sets Out Board and Committee Structure
1M ago
2616
CStone Pharmaceuticals’ GAVRETO® Gains Inclusion in China’s National Reimbursement Drug List
PremiumCompany Announcements
CStone Pharmaceuticals’ GAVRETO® Gains Inclusion in China’s National Reimbursement Drug List
3M ago
2616
CStone’s Sugemalimab Gains European Approval for Broader NSCLC Treatment
PremiumCompany Announcements
CStone’s Sugemalimab Gains European Approval for Broader NSCLC Treatment
3M ago
2616
CStone Pharmaceuticals Unveils CS2015 at ACAAI 2025
PremiumCompany Announcements
CStone Pharmaceuticals Unveils CS2015 at ACAAI 2025
4M ago
2616
CStone Pharmaceuticals Advances CS2009 Clinical Trials with NMPA Approval
PremiumCompany Announcements
CStone Pharmaceuticals Advances CS2009 Clinical Trials with NMPA Approval
4M ago
2616
CStone Pharmaceuticals Announces Board Composition and Roles
PremiumCompany AnnouncementsCStone Pharmaceuticals Announces Board Composition and Roles
4M ago
2616
CStone Pharmaceuticals Announces Board Changes with New Appointment
Premium
Company Announcements
CStone Pharmaceuticals Announces Board Changes with New Appointment
4M ago
2616
CStone Pharmaceuticals CEO Increases Shareholding, Signaling Confidence in Future Growth
Premium
Company Announcements
CStone Pharmaceuticals CEO Increases Shareholding, Signaling Confidence in Future Growth
4M ago
2616
CStone Pharmaceuticals Unveils Promising Phase I Data for Innovative Cancer Therapy
PremiumCompany Announcements
CStone Pharmaceuticals Unveils Promising Phase I Data for Innovative Cancer Therapy
4M ago
2616
CStone Pharmaceuticals Gains CHMP Positive Opinion for Sugemalimab in Stage III NSCLC
PremiumCompany Announcements
CStone Pharmaceuticals Gains CHMP Positive Opinion for Sugemalimab in Stage III NSCLC
4M ago
2616
CStone Pharmaceuticals to Present Groundbreaking Clinical Data at ESMO 2025
PremiumCompany Announcements
CStone Pharmaceuticals to Present Groundbreaking Clinical Data at ESMO 2025
5M ago
2616
CStone Pharmaceuticals Initiates Global Phase II Trial for Innovative Cancer Therapy
PremiumCompany Announcements
CStone Pharmaceuticals Initiates Global Phase II Trial for Innovative Cancer Therapy
5M ago
2616
CStone Pharmaceuticals Appoints Kenneth Jarrett as Independent Director
PremiumCompany AnnouncementsCStone Pharmaceuticals Appoints Kenneth Jarrett as Independent Director
5M ago
2616
CStone Pharmaceuticals Announces Board Composition and Roles
Premium
Company Announcements
CStone Pharmaceuticals Announces Board Composition and Roles
5M ago
2616
CStone Pharmaceuticals to Present Novel Antibody at ACAAI 2025
Premium
Company Announcements
CStone Pharmaceuticals to Present Novel Antibody at ACAAI 2025
5M ago
2616

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >